Jeffrey J. Brown - Nov 4, 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Stock symbol
MED
Transactions as of
Nov 4, 2022
Transactions value $
$60,205
Form type
4
Date filed
11/10/2022, 05:33 PM
Previous filing
Oct 27, 2022
Next filing
Jan 5, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Purchase $1.27K +11.9 +0.5% $106.93 2.37K Nov 8, 2022 Direct F1
transaction MED Common Stock Purchase $58.9K +561 +1.56% $105.06 36.5K Nov 4, 2022 By Brown Equity Partners, LLC F2, F3
holding MED Common Stock 3.94K Nov 4, 2022 Jeffrey Brown Living Trust F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired pursuant to a dividend reinvestment feature in connection with deferred units held by the Reporting Person pursuant to the Medifast, Inc. Director's Deferred Compensation Plan (Amended and Restated). The shares accrued when and as dividends were paid on Medifast common stock.
F2 The shares were acquired by Brown Equity Partners, LLC, for which the reporting person is the managing member, pursuant to a broker-sponsored Dividend Reinvestment Plan.
F3 These shares are directly owned by Brown Equity Partners, LLC, for which the reporting persons is the managing member.
F4 These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.